Biotech Strategy Blog

Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Cancer Immunotherapy

  • Posts
    • AACR18
    • AACR17
    • AACR16
    • AACR15
    • AACR14
    • AACR IO
    • AAI ASGCT 2015 New Orleans
    • ASCO-SITC
    • ASCO18
    • ASCO17
    • ASCO16
    • ASCO15
    • ASCO14
    • ASCO GU18
    • ASCO GI18
    • ASCO GI 2017
    • ASCO GU CI 2016
    • ASCO GI GU 2015
    • ASCO GI GU 2014
    • ASH17
    • ASH16
    • ASH15
    • ASH14
    • ASH13
    • AUA 2015
    • AUA 2014
    • BMT Tandem
    • CIML40
    • EACR
    • EAU 2015 Congress
    • EBMT15
    • ESMO IO
    • ESMO17
    • ESMO16
    • ECC 2015
    • ESMO14
    • ECC 2013
    • European Breast Cancer Conference
    • European Lung Cancer Conf
    • JPM18
    • JPM17
    • JPM16
    • JPM15
    • JPM14
    • Miami Breast Cancer Conference
    • Targets17
    • Mol Targets 2016
    • Molecular Targets
    • SABCS17
    • SABCS16
    • SABCS15
    • SABCS14
    • SABCS13
    • SGO
    • SITC 2017
    • SITC 2016
    • SITC 2015
    • SITC 2014
    • WCLC
  • About
  • Contact
  • Interviews
  • ESMO18
  • Immuno-Oncology
  • Premium Content
  • Pricing
  • Login

  • ESMO18 Live Blog Day 1

    Read more
  • View of Cambridge and Charles River

    A new prime and boost cell therapy for treating cancer?

    Read more

  • ESMO18 Preview 5 – A look at the evolving Renal Cell Carcinoma landscape

    Read more

  • An update on key SCLC trials

    Read more

  • ESMO18 Preview 4 Gems from the Poster Halls

    Read more

  • ESMO18 Preview 3 Top 10 Oral Abstracts

    Read more

  • New developments in neoantigen vaccines

    Read more

  • Update on CAR T cell therapies at CICON18

    Read more

  • CICON18 Day 1 Highlights

    Read more

  • ESMO18 Preview 1 Late Breakers What To Watch Out For

    Read more

  • WCLC2018 Roundup of key lung cancer data

    Read more
E

ESMO18 Live Blog Day 1

Highlights from Day 1 of #ESMO18 in Munich

View post
E
View of Cambridge and Charles River

A new prime and boost cell therapy for treating cancer?

Can we use technology to squeeze more out of B cells to generate an army of killer T cells?

View post
E

ESMO18 Preview 5 – A look at the evolving Renal Cell Carcinoma landscape

The changing face of renal cell cancer from several perspectives

View post

Terms of Use & Privacy Policy
Copyright © 2010-18 Biotech Strategy Blog

Sign Up for New Post Alerts
error: Content is protected !!